|
Turnstone Biologics Corp (NASDAQ: TSBX) |
|
Turnstone Biologics Corp
TSBX's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Turnstone Biologics 's sales fell
in III. Quarter 2024 from the same quarter a year ago.
Biotechnology & Pharmaceuticals industry recorded
growth of revenues by 13.29 %
Turnstone Biologics net loss decreased from $-17 millions, to $-17 millions in III. Quarter 2024,
• More on TSBX's Growth
|
|
Turnstone Biologics realized a net loss in trailing twelve months.
Turnstone Biologics realized cash reduction of $ -0.64 per share in trailing twelve-month period. Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.4.
• More on TSBX's Valuation
|
|
|
|
|
Turnstone Biologics realized net loss in trailing twelve months.
Turnstone Biologics realized cash outflow of $ -0.64per share in trailing twelve-month period. Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.4.
Turnstone Biologics Price to Book Ratio is at 0.27 higher than Industry Avg. of -0, and higher than S&P 500 Avg. of 0.01
• More on TSBX's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com